
About Novo Nordisk
Novo Nordisk is a Healthcare company based in Plainsboro (United States) founded in 1923. Novo Nordisk is focused on developing pharmaceutical treatments. It operates on a HealthTech model. The company has 2 employees. Its website novonordisk-us.com draws about 89 thousand monthly visits. Novo Nordisk offers products and services including Awiqli, Mim8, and Wegovy. Its focus areas include Pharmaceuticals and Biotechnology. Its legal entity is Novo Nordisk A/S. Its competitors include iMedX, Centivo and Omega Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
Novo Nordisk is engaged in the development and provision of pharmaceutical solutions primarily targeting diabetes, obesity, hemophilia, and growth hormone disorders. The company is recognized for innovative treatments such as Awiqli, a potential once-weekly basal insulin for type 2 diabetes, Mim8 for hemophilia A prophylaxis, and Wegovy for obesity management. Operations are centered in the healthcare sector with a commitment to sustainable business practices and partnerships for innovation.
- Headquarters Plainsboro, United States
- Employees 2
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website novonordisk-us.com
- Social X Facebook Instagram
- Legal Name Novo Nordisk A/S
- Employee Count2
Products & Services of Novo Nordisk
Novo Nordisk offers a comprehensive portfolio of products and services, including Awiqli, Mim8, and Wegovy.
Awiqli is developed as once-weekly basal insulin treatment.
Mim8 is investigated for hemophilia A prophylaxis treatment.
Wegovy is formulated for obesity weight loss treatment.
People of Novo Nordisk
1136 people are tracked at Novo Nordisk (545 in leadership, 9 in board & advisors, 582 in team); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Anne-Kristine Prag Steinitz | Corporate Vice President Strategic Scientific Communication, Global Medical Affairs | Leadership |
Cecilie Heerdegen Jepsen | Head Of Translational Medicine | Leadership |
Malgorzata Wnuk | Strategic Finance & Project Director | Leadership |
Allegra Kaufman | Executive Director, Clinical Development Strategy | Leadership |
Greg Horikoshi | Associate Director Commercial Execution | Leadership |
Claudia Laven | Vice President | Obesity Care | Leadership |
David Scott | Director, Legal, Ethics, Compliance And Quality | Leadership |
Sofie Inari Castella | Global Director, Scientific Publications | Leadership |
Rasmus Sonne Henniker Heaton | Sr. Business & Project Partner | Leadership |
Ghita Bahbouhi | Supply Chain Analytics Partner | Leadership |
Teresa Sophie K. | Director, IME & Medical Association Partnerships | Leadership |
Ulrik Ullum | Senior Director | Leadership |
Katy Long | Snr Dir, HR Business Partner, International Operations | Leadership |
Victor Vazquez | Talent Acquisition Partner Americas (latam, USA & Canada) | Leadership |
Al Willis | Senior Director - Deployment Strategy & Sales Innovation | Leadership |
Morten Engelund | Corporate Vice President, Total Rewards And Mobility | Leadership |
Briana Dunn | Associate Director Search And Evaluation | Leadership |
Jacob Sten Petersen | Corporate Vice President, Stem Cell R&D | Leadership |
Konstantinos Ratsikas | Senior Supply Chain Partner | Leadership |
Pratik Dherange | Associate Director, Regulatory Affairs Strategy | Leadership |
1116 more people are available in the full profile.
Complete people profiles for Novo Nordisk
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Novo Nordisk
Novo Nordisk has 3 listed competitors in our database, 2 of them funded. They include iMedX, Centivo and Omega Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imedx.com | 2002 | Atlanta, United States | $22.28M | 951 | Revenue cycle management platform is provided to healthcare providers. | |
| centivo.com | 2017 | New York, United States | $224M | 212 | Provider of self funded health plan | |
| omegahms.com | 2003 | Boca Raton, United States | 26,750 | Healthcare outsourcing services are provided to various sectors. |
Detailed competitors of Novo Nordisk
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Novo Nordisk
The website of Novo Nordisk (novonordisk-us.com) receives about 89K visits a month and ranks #469,241 among all websites worldwide, #447 in Biotechnology and Pharmaceuticals.
- Monthly visits89K
▲ 13.2% vs previous month
- Unique visitors45.4K
per month
- Global rank#469,241
among all websites
- Category rank#447
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.9
- Average visit36 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Novo Nordisk. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novonordisk.com | 96% | 637.8K | #83,485 | View details | |
| catalent.com | 83% | 116.7K | #338,870 | View details | |
| daiichisankyo.com | 83% | 72.3K | #682,883 | View details | |
| sterlingpharmasolutions.com | 78% | 12.2K | #2,060,032 | View details | |
| eisai.com | 77% | 74.5K | #534,857 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Novo Nordisk
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as Novo Nordisk (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novo Nordisk
Complete news archive for Novo Nordisk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novo Nordisk
Novo Nordisk was founded in 1923.
Novo Nordisk is headquartered in Plainsboro, United States. It is registered at Plainsboro, New Jersey, United States.
Novo Nordisk has 2 employees.
Novo Nordisk is engaged in the development and provision of pharmaceutical solutions primarily targeting diabetes, obesity, hemophilia, and growth hormone disorders. The company is recognized for innovative treatments such as Awiqli, a potential once-weekly basal insulin for type 2 diabetes, Mim8 for hemophilia A prophylaxis, and Wegovy for obesity management. Operations are centered in the healthcare sector with a commitment to sustainable business practices and partnerships for innovation.
Novo Nordisk's top competitors include Centivo, Omega Healthcare and iMedX.
Novo Nordisk offers Awiqli, Mim8, and Wegovy.
Novo Nordisk operates through Novo Nordisk A/S.
